SE428378B - Analogiforfarande for framstellning av droxanderivat - Google Patents

Analogiforfarande for framstellning av droxanderivat

Info

Publication number
SE428378B
SE428378B SE7701796A SE7701796A SE428378B SE 428378 B SE428378 B SE 428378B SE 7701796 A SE7701796 A SE 7701796A SE 7701796 A SE7701796 A SE 7701796A SE 428378 B SE428378 B SE 428378B
Authority
SE
Sweden
Prior art keywords
droxand
derivatives
preparing
analogy procedure
analogy
Prior art date
Application number
SE7701796A
Other languages
English (en)
Other versions
SE7701796L (sv
Inventor
R N Booher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7701796L publication Critical patent/SE7701796L/sv
Publication of SE428378B publication Critical patent/SE428378B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7701796A 1972-12-08 1977-02-17 Analogiforfarande for framstellning av droxanderivat SE428378B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31322172A 1972-12-08 1972-12-08

Publications (2)

Publication Number Publication Date
SE7701796L SE7701796L (sv) 1977-02-17
SE428378B true SE428378B (sv) 1983-06-27

Family

ID=23214841

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7316586A SE403377B (sv) 1972-12-08 1973-12-07 Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan
SE7701795A SE417196B (sv) 1972-12-08 1977-02-17 Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer
SE7701796A SE428378B (sv) 1972-12-08 1977-02-17 Analogiforfarande for framstellning av droxanderivat

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE7316586A SE403377B (sv) 1972-12-08 1973-12-07 Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan
SE7701795A SE417196B (sv) 1972-12-08 1977-02-17 Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer

Country Status (27)

Country Link
JP (2) JPS5742633B2 (sv)
AR (3) AR206306A1 (sv)
AT (2) AT332396B (sv)
BE (1) BE808340A (sv)
BG (4) BG21223A3 (sv)
CA (2) CA1014560A (sv)
CH (4) CH614439A5 (sv)
CS (3) CS222209B2 (sv)
CY (1) CY1017A (sv)
DD (3) DD109625A5 (sv)
DE (1) DE2361340C2 (sv)
DK (1) DK134717B (sv)
ES (4) ES421291A1 (sv)
FR (1) FR2209578B1 (sv)
GB (2) GB1455997A (sv)
HK (1) HK60479A (sv)
HU (2) HU168763B (sv)
IE (1) IE40226B1 (sv)
IL (1) IL43773A (sv)
KE (1) KE2976A (sv)
MY (1) MY8000064A (sv)
NL (1) NL7316839A (sv)
PH (2) PH15197A (sv)
SE (3) SE403377B (sv)
SU (4) SU587861A3 (sv)
YU (3) YU36171B (sv)
ZA (1) ZA739207B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2847177B1 (en) * 2012-05-09 2017-10-11 Boehringer Ingelheim International GmbH Methods for making oxetan-3-ylmethanamines
LV14983B (lv) * 2013-10-15 2015-06-20 Olainfarm, A/S Fenibuta ražošanas starpproduktu iegūšanas paņēmiens

Also Published As

Publication number Publication date
DE2361340A1 (de) 1974-06-12
YU36020B (en) 1981-11-13
JPS4987680A (sv) 1974-08-22
DD109625A5 (sv) 1974-11-12
AR206306A1 (es) 1976-07-15
YU318473A (en) 1980-09-25
AT332396B (de) 1976-09-27
PH14923A (en) 1982-01-29
CA1014560A (en) 1977-07-26
BG21409A3 (bg) 1976-05-20
IL43773A0 (en) 1974-03-14
ES421291A1 (es) 1976-07-01
CA1024150A (en) 1978-01-10
CS222209B2 (en) 1983-05-27
ES444716A1 (es) 1977-05-16
SE7701795L (sv) 1977-02-17
PH15197A (en) 1982-09-17
SU648081A3 (ru) 1979-02-15
ZA739207B (en) 1975-07-30
YU109380A (en) 1981-04-30
CH605903A5 (sv) 1978-10-13
HK60479A (en) 1979-08-31
CS222208B2 (en) 1983-05-27
HU168763B (sv) 1976-07-28
GB1455997A (en) 1976-11-17
CH630914A5 (en) 1982-07-15
BG22386A3 (bg) 1977-02-20
IL43773A (en) 1979-05-31
AU6321773A (en) 1975-06-05
ES444911A1 (es) 1977-09-01
MY8000064A (en) 1980-12-31
NL7316839A (sv) 1974-06-11
SU587861A3 (ru) 1978-01-05
CY1017A (en) 1979-11-23
DE2361340C2 (de) 1983-11-24
ES421290A1 (es) 1976-07-01
SU663305A3 (ru) 1979-05-15
CH619219A5 (en) 1980-09-15
IE40226B1 (en) 1979-04-11
YU318573A (en) 1981-06-30
JPS5734835B2 (sv) 1982-07-26
DK134717B (da) 1977-01-03
AR212012A1 (es) 1978-04-28
HU168620B (sv) 1976-06-28
BG21223A3 (bg) 1976-03-20
DD115653A5 (sv) 1975-10-12
YU36171B (en) 1982-02-25
SE403377B (sv) 1978-08-14
DK134717C (sv) 1977-05-31
CH614439A5 (en) 1979-11-30
FR2209578B1 (sv) 1977-09-02
CS193480B2 (en) 1979-10-31
SE7701796L (sv) 1977-02-17
FR2209578A1 (sv) 1974-07-05
YU35447B (en) 1981-02-28
GB1455998A (en) 1976-11-17
ATA1026073A (de) 1975-10-15
IE40226L (en) 1974-06-08
BG26205A4 (bg) 1979-02-15
AT330773B (de) 1976-07-26
KE2976A (en) 1979-07-20
ATA1026173A (de) 1976-01-15
SU578001A3 (ru) 1977-10-25
JPS5742633B2 (sv) 1982-09-09
DD110864A5 (sv) 1975-01-12
AR212416A1 (es) 1978-07-14
SE417196B (sv) 1981-03-02
BE808340A (fr) 1974-06-07
JPS4987681A (sv) 1974-08-22

Similar Documents

Publication Publication Date Title
SE382059B (sv) Forfarande for framstellning av nya substituerade piperidinderivat
SE395366B (sv) Forfarande for framstellning av porosa tabletter
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
SE417968B (sv) Forfarande for framstellning av penamderivat
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
NO139124C (no) Fremgangsmaate for fremstilling av estere
DK151628C (da) Analogifremgangsmaade til fremstilling af benzimidazolderivater
SE423092B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE7611202L (sv) Forfarande for framstellning av pyrazolodiazepinforeningar
FI55626B (fi) Anordning foer framstaellning av en behaollare
NO139130C (no) Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner
SE417198B (sv) Analogiforfarande for framstellning av alkanolaminderivat
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
SE397088B (sv) Forfarande for framstellning av nya 2-propanolderivat
SE416953B (sv) Analogiforfarande for framstellning av substituerade fenylamidinokarbamidforeningar
SE385581B (sv) Forfarande for framstellning av foretrade n-metylolkarbamidforeningar
SE393376B (sv) Forfarande for framstellning av pyrimidinonderivat
FI53452C (fi) Foerfarande foer framstaellning av n-laegre-alkyl-1,4-dihydro-4-oxokinolin-3-karboxylsyror
SE402454B (sv) Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen
SE384510B (sv) Forfarande for framstellning av nya isoindolinpiperazinderivat
SE409858B (sv) Forfarande for framstallning av vissa angivna aminoalkylfenylacetonitrilderivat